Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Telomeres and telomerase linked to cancer, age-related changes

March 15, 1999

Sangamo enters agreement with Japan Tobacco for validation of novel gene targets

March 12, 1999

Genelabs presents gene switch application

March 10, 1999

Novel AD and metabolic syndrome targets as focus of Exelixis and P&U collaboration

March 8, 1999

KV Pharmaceutical and Pfizer sign licensing agreement for oral delivery system

March 4, 1999

Positive efficacy and safety results support clinical testing of ViaStem

March 4, 1999

HMN-1108: new small-molecule compound specific for nNOS

March 2, 1999

LeukoSite and Medarex expand HuMab-Mouse licensing agreement

March 2, 1999

Atrix expands drug delivery patent portfolio

March 1, 1999

Palatin awarded 4th and 5th SBIR grants for MIDAS technology

March 1, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...